Risk of ischemic and hemorrhagic complications associated with continuation versus interruption of antithrombotic therapy for cervical transforaminal injections: A retrospective study
Risk of ischemic and hemorrhagic complications associated with continuation versus interruption of antithrombotic therapy for cervical transforaminal injections: A retrospective study. // Interventional Pain Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S2772594426000853?dgcid=rss_sd_all
Risk of ischemic and hemorrhagic complications associated with continuation versus interruption of antithrombotic therapy for cervical transforaminal injections: A retrospective study. Interventional Pain Medicine. https://www.sciencedirect.com/science/article/pii/S2772594426000853?dgcid=rss_sd_all
“Risk of ischemic and hemorrhagic complications associated with continuation versus interruption of antithrombotic therapy for cervical transforaminal injections: A retrospective study.” Interventional Pain Medicine.
@article{article50522,
title = {Risk of ischemic and hemorrhagic complications associated with continuation versus interruption of antithrombotic therapy for cervical transforaminal injections: A retrospective study},
journal = {Interventional Pain Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S2772594426000853?dgcid=rss_sd_all}
}
ABSTRACT Background For half the world's population, headaches represent a major health burden that cripples productivity and mental well‐being. While newer CGRP‐targeted drugs have shown promise for migraines, less is known about how...